Lirilumab, CAS [[1000676-41-4]]

Produktübersicht

• Artikelname: Lirilumab, CAS [[1000676-41-4]]
• Artikelnummer: TGM-T77423
• Hersteller Artikelnummer: T77423
• Alternativnummer: TGM-T77423-1MG,TGM-T77423-5MG,TGM-T77423-10MG,TGM-T77423-25MG,TGM-T77423-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ONO-4483 , IPH2102

Produktbeschreibung

Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical cancer activity of natural killer cells through VAV1-dependent NF-kappaB deinhibition. It can be used to study leukemia, head and neck squamous cell carcinoma (SCCHN).

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1000676-41-4]
• Target-Kategorie: Virus Protease